The team at Sunnybrook’s Hurvitz Brain Sciences Research Program is making impressive progress with the help of their lab-grown organoids.

Here, Dr. Peter Nord explores how these advances could change the way we treat Alzheimer’s disease and dementia, and how your lifestyle choices might affect whether or not you actually develop a cognitive disease. He’s joined by renowned neurologist Dr. Sandra Black, (pictured above) who leads the Dr. Sandra Black Centre For Brain Resilience and Recovery, and Director of Sunnybrook’s Biological Sciences Platform. Dr. JoAnne McLaurin.

Last year, Medcan director of weight management Dr. David Macklin (pictured above) predicted the diabetes medication semaglutide would be a game changer for those seeking help to lose weight. So we invited back Dr. Macklin to get his perspective on the medication, now that it’s actually on the market and being used by hundreds of thousands of people across North America. Joined by Medcan CMO Dr. Peter Nord, Dr. Macklin explains semaglutide’s benefits, side effects and costs — and describes what’s different about Medcan’s approach to weight management in the semaglutide era.